A phase I trial of lapatinib in combination with carboplatin in patients with platinum sensitive recurrent epithelial ovarian cancer

被引：0
|
作者：
Kimball, K. J. [1 ]
Numnum, T. M. [1 ]
Estes, J. M. [1 ]
Kirby, T. O. [1 ]
Barnes, M. N. [1 ]
Alvarez, R. D. [1 ]
机构：
[1] UAB, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14106
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
    Secord, A. Alvarez
    Havrilesky, L. J.
    Higgins, R. V.
    Nycum, L. R.
    Kohler, M. F.
    Puls, L. E.
    Holloway, R.
    Soper, J. T.
    Valea, F. A.
    Berchuck, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 278S - 278S
  • [22] PHASE I/II STUDY OF CARBOPLATIN AND PRALATREXATE IN PATIENTS WITH RECURRENT PLATINUM SENSITIVE OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER
    del Carmen, M.
    Campos, S.
    Krasner, C.
    Berlin, S.
    Supko, J.
    Atkinson, T.
    Birrer, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 419 - 420
  • [23] A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer
    Sehouli, Jalid
    Alvarez, Ana Maria
    Manouchehrpour, Shokoufeh
    Ghatage, Prafull
    Szczylik, Cezary
    Zimmermann, Annamaria
    Bauknecht, Thomas
    Look, Katherine Y.
    Oskay-Oeezcelik, Gultan
    GYNECOLOGIC ONCOLOGY, 2012, 124 (02) : 205 - 209
  • [24] Phase I feasibility study of carboplatin plus capecitabine followed by maintenance capecitabine in patients (pts) with recurrent platinum-sensitive epithelial ovarian cancer (EOC)
    Montes, A.
    Sandhu, S. K.
    Rothermundt, C.
    Coombes, I.
    A'Hern, R.
    Keyzor, C.
    Thomas, A.
    Kaye, S.
    Gore, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer
    Secord, Angeles Alvarez
    Berchuck, Andrew
    Higgins, Robert V.
    Nycum, Lawrence R.
    Kohler, Matthew F.
    Puls, Larry E.
    Holloway, Robert W.
    Lewandowski, George S.
    Valea, Fidel A.
    Havrilesky, Laura J.
    CANCER, 2012, 118 (13) : 3283 - 3293
  • [26] Randomized phase III study comparing paclical-carboplatin with paclitaxel-carboplatin in patients with recurrent platinum-sensitive epithelial ovarian cancer.
    Vergote, Ignace
    Brize, Arija
    Lisyanskaya, Alla Sergeevua
    Lichinitser, Mikhail
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer
    Ramirez, Pedro T.
    Landen, Charles N., Jr.
    Coleman, Robert L.
    Milam, Michael R.
    Levenback, Charles
    Johnston, Taren A.
    Gershenson, David M.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (01) : 68 - 71
  • [28] Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study
    Koensgen, Dominique
    Stengel, Dirk
    Belau, Antje
    Klare, Peter
    Oskay-Oezcelik, Guelten
    Steck, Thomas
    Camara, Oumar
    Mustea, Alexander
    Sommer, Harald
    Coumbos, Alexandra
    Bogenrieder, Thomas
    Lichtenegger, Werner
    Sehouli, Jalid
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) : 393 - 400
  • [29] Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study
    Dominique Koensgen
    Dirk Stengel
    Antje Belau
    Peter Klare
    Guelten Oskay-Oezcelik
    Thomas Steck
    Oumar Camara
    Alexander Mustea
    Harald Sommer
    Alexandra Coumbos
    Thomas Bogenrieder
    Werner Lichtenegger
    Jalid Sehouli
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 393 - 400
  • [30] Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
    Meteran, Hanieh
    Knudsen, Anja Or
    Jorgensen, Trine Lembrecht
    Nielsen, Dorte
    Herrstedt, Jorn
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
12345